| | | | | | | | | | |
| Dockets Management
|
|
| Dockets Entered On June 19, 2006
|
|
|
|
|
|
|
| |
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
| |
|
|
| 2003E-0030
|
| Patent Term Extension Application for FASLODEX No. 4,659,516
|
| |
|
|
| 2003E-0254
|
| Patent Extension for Inspra (eplerenone), 4,559,332
|
| |
|
|
| 2003E-0407
|
| Patent Term Restoration Application for Cypher, U.S. Patent No. 5,563,146
|
| |
|
|
| 2003E-0418
|
| Emend (Aprepitant), Patent Term Extension Application; U.S. Patent No. 5,719,147
|
| |
|
|
| 2004E-0019
|
| Patent Extension, FUZEON (enfuvirtide), U.S. Patent No. 6,133,418
|
| |
|
|
| 2004E-0039
|
| Patent Extension for CRESTOR (rosuvastatin), U.S. Patent No. RE37,314
|
| |
|
|
| 2004E-0307
|
| Patent Extension for Altima (pemetrexed), U.S. Patent No. 5,344,932
|
| |
|
|
| 2004E-0394
|
| Patent Extension for ALOXI (palonosetron hydrochloride) injection, U.S. Patent No. 5,202,333
|
| |
|
|
| 2004E-0445
|
| Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382
|
| |
|
|
| 2005E-0254
|
| Patent Extension Application for ERBITUX, U.S. Patent No. 6,217,866
|
| |
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
| |
|
|
| 2006E-0022
|
| Patent Extension Application for SYMLIN (pramlintide acetate), U.S. Patent No. 5,686,411
|
| |
|
|
| 2006N-0222
|
| Merck & Co., Inc. et al.; Withdrawal of Approval of 65 New Drug Applications and 52 Abbreviated New Drug Applications
|
| |
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET 17889
|
| New Chapter, Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17890
|
| New Chapter, Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17891
|
| New Chapter, Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17892
|
| New Chapter, Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17893
|
| Pharmavite LLC
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17894
|
| Eu Yan Sang (Hong Kong) Limited
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17895
|
| Ortho Molecular Products, Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17896
|
| Ortho Molecular Products, Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17897
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17898
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17899
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17900
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17901
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17902
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17903
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17904
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17905
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17906
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17907
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17908
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
|
| | | | | | | | |
| |
|
|
| LET 17909
|
| Source Naturals
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17910
|
| Enzymatic Therapy
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17911
|
| Enzymatic Therapy
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17912
|
| Enzymatic Therapy
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17913
|
| Enzymatic Therapy
|
| Vol #:
|
| 165
|
| |
|
|
| LET 17914
|
| NBTY Inc.
|
| Vol #:
|
| 165
|
| |
|
|
| 2003E-0030
|
| Patent Term Extension Application for FASLODEX No. 4,659,516
|
| |
|
|
| LET 5
|
| HFD-005 to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| LET 6
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2003E-0254
|
| Patent Extension for Inspra (eplerenone), 4,559,332
|
| |
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2003E-0407
|
| Patent Term Restoration Application for Cypher, U.S. Patent No. 5,563,146
|
| |
|
|
| LET 4
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2003E-0418
|
| Emend (Aprepitant), Patent Term Extension Application; U.S. Patent No. 5,719,147
|
| |
|
|
| LET 3
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2004E-0019
|
| Patent Extension, FUZEON (enfuvirtide), U.S. Patent No. 6,133,418
|
| |
|
|
| LET 3
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2004E-0039
|
| Patent Extension for CRESTOR (rosuvastatin), U.S. Patent No. RE37,314
|
| |
|
|
| LET 4
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2004E-0307
|
| Patent Extension for Altima (pemetrexed), U.S. Patent No. 5,344,932
|
| |
|
|
| LET 4
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2004E-0394
|
| Patent Extension for ALOXI (palonosetron hydrochloride) injection, U.S. Patent No. 5,202,333
|
| |
|
|
| LET 4
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2004E-0445
|
| Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382
|
| |
|
|
| LET 4
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0254
|
| Patent Extension Application for ERBITUX, U.S. Patent No. 6,217,866
|
|
|
| LET 5
|
| U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
| |
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
| |
|
|
| C 13261
|
| D. Tilstra
|
| Vol #:
|
| 154
|
| |
|
|
| C 13262
|
| R. Harness
|
| Vol #:
|
| 154
|
|
| | | | | | | |
| |
|
|
| C 13263
|
| J. Ward
|
| Vol #:
|
| 154
|
| |
|
|
| C 13264
|
| J. Morrill
|
| Vol #:
|
| 154
|
| |
|
|
| C 13265
|
| S. Miller
|
| Vol #:
|
| 154
|
| |
|
|
| C 13266
|
| M. Scott
|
| Vol #:
|
| 154
|
| |
|
|
| C 13267
|
| P. Ellis
|
| Vol #:
|
| 154
|
| |
|
|
| C 13268
|
| L. Mailhot
|
| Vol #:
|
| 154
|
| |
|
|
| C 13269
|
| T. Snelson
|
| Vol #:
|
| 154
|
| |
|
|
| C 13270
|
| Eligible
|
| Vol #:
|
| 154
|
| |
|
|
| C 13271
|
| C. Young
|
| Vol #:
|
| 154
|
| |
|
|
| C 13272
|
| Eligible
|
| Vol #:
|
| 154
|
| |
|
|
| C 13273
|
| N. Lewis
|
| Vol #:
|
| 154
|
| |
|
|
| C 13274
|
| D. McCarthy
|
| Vol #:
|
| 154
|
| |
|
|
| C 13275
|
| K. Bajus
|
| Vol #:
|
| 154
|
| |
|
|
| C 13276
|
| Eligible
|
| Vol #:
|
| 155
|
| |
|
|
| C 13277
|
| P. Snyder
|
| Vol #:
|
| 155
|
| |
|
|
| C 13278
|
| C. Schroeder
|
| Vol #:
|
| 155
|
| |
|
|
| C 13279
|
| L. Weidlein
|
| Vol #:
|
| 155
|
| |
|
|
| C 13280
|
| M. Witherbee
|
| Vol #:
|
| 155
|
| |
|
|
| C 13281
|
| J. Mahon
|
| Vol #:
|
| 155
|
| |
|
|
| C 13282
|
| D. Emerson
|
| Vol #:
|
| 155
|
| |
|
|
| C 13283
|
| G. Bergeron
|
| Vol #:
|
| 155
|
| |
|
|
| C 13284
|
| L. Tri
|
| Vol #:
|
| 155
|
| |
|
|
| C 13285
|
| J. Aharonian
|
| Vol #:
|
| 155
|
| |
|
|
| C 13286
|
| S. Reid
|
| Vol #:
|
| 155
|
| |
|
|
| C 13287
|
| L. Johnson
|
| Vol #:
|
| 155
|
| |
|
|
| C 13288
|
| S. Narlock
|
| Vol #:
|
| 155
|
| |
|
|
| C 13289
|
| B. Cortner
|
| Vol #:
|
| 155
|
| |
|
|
| C 13290
|
| J. Mullen
|
| Vol #:
|
| 155
|
| |
|
|
| C 13291
|
| L. Sanderson
|
| Vol #:
|
| 155
|
| |
|
|
| C 13292
|
| B. Haynes
|
| Vol #:
|
| 155
|
| |
|
|
| C 13293
|
| M. Haynes
|
| Vol #:
|
| 155
|
| |
|
|
| C 13294
|
| J. Weidlein
|
| Vol #:
|
| 155
|
| |
|
|
| C 13295
|
| M. Schmidt
|
| Vol #:
|
| 155
|
| |
|
|
| C 13296
|
| A. Bennett
|
| Vol #:
|
| 155
|
| |
|
|
| C 13297
|
| M. Marra
|
| Vol #:
|
| 155
|
| |
|
|
| C 13298
|
| J. McNeil
|
| Vol #:
|
| 155
|
| |
|
|
| C 13299
|
| J. McNeil
|
| Vol #:
|
| 155
|
|
| | | | | | | | |
| |
|
|
| C 13300
|
| A. Hablutzel
|
| Vol #:
|
| 155
|
| |
|
|
| C 13301
|
| T. Garland
|
| Vol #:
|
| 155
|
| |
|
|
| C 13302
|
| D. Oliver
|
| Vol #:
|
| 155
|
| |
|
|
| C 13303
|
| T. Dallas
|
| Vol #:
|
| 155
|
| |
|
|
| C 13304
|
| T. Culverhouse
|
| Vol #:
|
| 155
|
| |
|
|
| C 13305
|
| S. Lerings
|
| Vol #:
|
| 155
|
| |
|
|
| C 13306
|
| C. Morrette
|
| Vol #:
|
| 155
|
| |
|
|
| C 13307
|
| Dr. J. Hofve
|
| Vol #:
|
| 155
|
| |
|
|
| C 13308
|
| D. Baltimore
|
| Vol #:
|
| 155
|
| |
|
|
| C 13309
|
| D. Anderson
|
| Vol #:
|
| 155
|
| |
|
|
| C 13310
|
| T. Rotberg
|
| Vol #:
|
| 155
|
| |
|
|
| C 13311
|
| P. Webb
|
| Vol #:
|
| 155
|
| |
|
|
| C 13312
|
| L. Davis
|
| Vol #:
|
| 155
|
| |
|
|
| C 13313
|
| S. Levings
|
| Vol #:
|
| 155
|
| |
|
|
| C 13314
|
| G. Calegari
|
| Vol #:
|
| 155
|
| |
|
|
| C 13315
|
| K. Brown
|
| Vol #:
|
| 155
|
| |
|
|
| C 13316
|
| A. Gilbert
|
| Vol #:
|
| 155
|
| |
|
|
| C 13317
|
| L. Solberg
|
| Vol #:
|
| 155
|
| |
|
|
| C 13318
|
| B. Hendrickson
|
| Vol #:
|
| 155
|
| |
|
|
| C 13319
|
| V. Lenz
|
| Vol #:
|
| 155
|
| |
|
|
| C 13320
|
| J. Kuler
|
| Vol #:
|
| 155
|
| |
|
|
| C 13321
|
| A. Russell
|
| Vol #:
|
| 155
|
| |
|
|
| C 13322
|
| C. Morgan
|
| Vol #:
|
| 155
|
| |
|
|
| C 13323
|
| C. Ray
|
| Vol #:
|
| 155
|
| |
|
|
| C 13324
|
| B. Homan
|
| Vol #:
|
| 155
|
| |
|
|
| C 13325
|
| S. Gavin
|
| Vol #:
|
| 155
|
| |
|
|
| C 13326
|
| C. Mayer
|
| Vol #:
|
| 155
|
| |
|
|
| C 13327
|
| R. Sevin
|
| Vol #:
|
| 155
|
| |
|
|
| C 13328
|
| N. LeBlanc
|
| Vol #:
|
| 155
|
| |
|
|
| C 13329
|
| M. Griffin
|
| Vol #:
|
| 155
|
| |
|
|
| SUP 1
|
| Wyeth
|
| Vol #:
|
| 155
|
| |
|
|
| 2006E-0022
|
| Patent Extension Application for SYMLIN (pramlintide acetate), U.S. Patent No. 5,686,411
|
| |
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2006N-0222
|
| Merck & Co., Inc. et al.; Withdrawal of Approval of 65 New Drug Applications and 52 Abbreviated New Drug Applications
|
| |
|
|
| NWL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
